Manchester Global Management UK Ltd raised its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 26.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 230,603 shares of the conglomerate’s stock after acquiring an additional 48,846 shares during the period. Danaher makes up 7.1% of Manchester Global Management UK Ltd’s holdings, making the stock its 5th biggest holding. Manchester Global Management UK Ltd’s holdings in Danaher were worth $52,790,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also made changes to their positions in the company. Bank Pictet & Cie Europe AG increased its position in shares of Danaher by 25.4% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock valued at $83,895,000 after acquiring an additional 74,301 shares during the last quarter. Maxi Investments CY Ltd acquired a new stake in shares of Danaher during the third quarter valued at about $3,251,000. Northwestern Mutual Wealth Management Co. increased its position in shares of Danaher by 303.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after acquiring an additional 186,584 shares during the last quarter. Defender Capital LLC. acquired a new stake in shares of Danaher during the fourth quarter valued at about $35,715,000. Finally, CIBC Bancorp USA Inc. purchased a new position in shares of Danaher in the third quarter valued at approximately $17,480,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Danaher Stock Up 0.3%
Shares of Danaher stock opened at $181.57 on Wednesday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a 50 day moving average of $180.54 and a 200 day moving average of $203.94. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $128.51 billion, a P/E ratio of 35.12, a P/E/G ratio of 2.31 and a beta of 0.81.
Danaher Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s payout ratio is currently 30.95%.
Analyst Ratings Changes
Several research analysts have recently commented on the stock. DZ Bank assumed coverage on shares of Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. Barclays lowered their price objective on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Evercore raised their price objective on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research note on Tuesday, April 21st. JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Finally, Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus target price of $233.61.
Get Our Latest Stock Report on Danaher
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
